In the tenth episode of the GHAPP & RhAPP Biosimilar Podcast Series, host Gabriella McCarty, NP-C, welcomes Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP to explore the practical use of biosimilars in gastroenterology APP practice.
They begin by reviewing key takeaways from the AGA Biosimilars Roundtable Meeting Report and the Crohn’s & Colitis Foundation Biosimilar Position Statement, which provide guidance on biosimilar safety, efficacy, and implementation in IBD treatment.
Sharon shares insights on biosimilars in Crohn’s disease and ulcerative colitis, discussing their effectiveness, safety, and patient outcomes. They examine how APPs can lead patient education, navigate insurance-mandated transitions, and optimize prior authorization processes to ensure seamless integration of biosimilars into practice.
Addressing common hesitations, they highlight the rigorous FDA approval process, real-world evidence, and provider confidence-building strategies. With practical tips for overcoming barriers, this episode serves as a concise guide for GI APPs adopting biosimilars in clinical care.
Tune in to gain actionable strategies for implementing biosimilars in gastroenterology and stay connected for the next episode in the GHAPP & RhAPP Biosimilar Podcast Series.
Visit the RhAPP website or explore additional educational content on the RhAPP ACE App.
Please take our evaluation regarding this podcast here: https://www.rhapp.org/bio-podcast-eval
